Search
Browse the Ada Lovelace Institute website.
Filter by:
Active filters:
Evaluating data-driven COVID-19 technologies through a human-centred approach
What we can learn from missing evidence on digital contact tracing and vaccine passports?
Pandemic preparedness and public health in the algorithmic age
Lessons from the App Store: Insights and learnings from COVID-19 technologies
Lessons from the App Store
Insights and learnings from COVID-19 technologies
Governments must learn ‘clear lessons’ from the use of digital technologies during the COVID-19 pandemic
COVID-19 was the first global health crisis of ‘the algorithmic age’.
COVID-19 technologies: international evidence, policy and practice
This project builds on work undertaken by the Ada Lovelace Institute in 2020 and 2021 to rapidly track, monitor and understand COVID-19 technologies.
Understanding COVID-19 certificates in the context of recent health securitisation trends
What narratives have framed pandemic-related technologies and who do they leave out?
The Ada Lovelace Institute in 2022
Ada’s Director Carly Kind reflects on the last year and looks ahead to 2023
International call for input: effectiveness and social impact of vaccine certificates and digital contact tracing
An open call for input from public health officials, civil society organisations, researchers and members of the public
How to improve contact tracing apps for future public health crises
Lessons learned from the UK’s response to the COVID-19 pandemic
The role of good governance and the rule of law in building public trust in data-driven responses to public health emergencies
Citizens' juries on the trustworthiness of data-driven technologies used in a public health emergency.
Public lacks access to, and has concerns about discriminatory impact of, COVID-19 related technologies
Findings from a survey of public attitudes towards a range of technologies deployed during the COVID-19 pandemic for health outcomes
The data divide
Public attitudes to tackling social and health inequalities in the COVID-19 pandemic and beyond